Celldex Therapeutics Inc. (NASDAQ: CLDX): Reassessing Prospects
Celldex Therapeutics Inc. (CLDX) concluded trading on Thursday at a closing price of $36.02, with 12.32 million shares of worth about $443.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.23% during that period and on September 25, 2024 the price saw a […]
Celldex Therapeutics Inc. (NASDAQ: CLDX): Hunting Genuine Value In Market Debris
Wellington Management Co. LLP recently announced the acquisition of new stake in Celldex Therapeutics Inc. (NASDAQ:CLDX). The institutional investor has increased its shareholding in the Healthcare company by 5.85% to 5.43 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 9.93% valued currently at $164.1 million. In addition, […]
